These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18790949)

  • 1. Optimizing approaches to head and neck cancer. Metastatic head and neck cancer: new options.
    Licitra L; Locati LD; Bossi P
    Ann Oncol; 2008 Sep; 19 Suppl 7():vii200-3. PubMed ID: 18790949
    [No Abstract]   [Full Text] [Related]  

  • 2. [A combination of radiotherapy and chemotherapy with platidiam and fluorouracil in patients with head and neck cancer].
    Shparyk IaV; Kravets AI; Bilyns'kyÄ­ BT; Kuftiak OF
    Lik Sprava; 1996; (3-4):153-7. PubMed ID: 9035857
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperthermia as an adjuvant to radiation- and/or chemotherapy in far advanced recurrences of the head and neck region.
    Steindorfer P; Jakse R; Germann R; Schneider G; Berger A; Mischinger HJ; Rehak P
    Strahlenther Onkol; 1987 Jul; 163(7):449-52. PubMed ID: 2441480
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy advances in head and neck oncology.
    Liggett W; Forastiere AA
    Semin Surg Oncol; 1995; 11(3):265-71. PubMed ID: 7638514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival following salvage reirradiation with concurrent chemotherapy for recurrent head and neck cancer.
    Watkins JM; Stuart RK; Davis BK; Day TA; Chaudharry UB; Sharma AK
    J S C Med Assoc; 2008 Feb; 104(2):36-9. PubMed ID: 18396601
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant chemotherapy after surgery and radiation for stage III and IV head and neck cancer.
    Huang AT; Cole TB; Fishburn R; Jelovsek SB
    Ann Surg; 1984 Aug; 200(2):195-9. PubMed ID: 6465974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for recurrent disease and combined modality therapies for head and neck cancer.
    Tavorath R; Pfister DG
    Curr Opin Oncol; 1995 May; 7(3):242-7. PubMed ID: 7654826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemo re-irradiation in recurrent head and neck cancer: a single institution experience.
    Katodritis N; Charalampous H; Vomvas D
    J BUON; 2012; 17(2):397. PubMed ID: 22740226
    [No Abstract]   [Full Text] [Related]  

  • 9. Future directions in the chemotherapy of head and neck cancer.
    Grunberg SM
    Am J Clin Oncol; 1985 Feb; 8(1):51-4. PubMed ID: 2581435
    [No Abstract]   [Full Text] [Related]  

  • 10. Patterns of failure among patients with squamous cell carcinoma of the head and neck who obtain a complete response to chemoradiotherapy.
    Yovino S; Settle K; Taylor R; Wolf J; Kwok Y; Cullen K; Ord R; Zimrin A; Strome S; Suntharalingam M
    Head Neck; 2010 Jan; 32(1):46-52. PubMed ID: 19484762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control after the use of adjuvant electron beam intraoperative radiotherapy in patients with high-risk head and neck cancer: the UCSF experience.
    Ling SM; Roach M; Fu KK; Coleman C; Chan A; Singer M
    Cancer J Sci Am; 1996; 2(6):321-9. PubMed ID: 9166552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of chemotherapy in the treatment of head and neck cancer.
    Inuyama Y; Fukuda S; Furuta Y; Yagi K; Nagahashi T; Chida E; Shirato H; Fujii M; Kanzaki J
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():52-9. PubMed ID: 9210888
    [No Abstract]   [Full Text] [Related]  

  • 13. [Reirradiation of head and neck cancers].
    Comet B; Lartigau E
    Cancer Radiother; 2010 Oct; 14(6-7):416-20. PubMed ID: 20810299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of the head and neck (SCCHN).
    Pivot X; Kataja VV; Jelic S;
    Ann Oncol; 2005; 16 Suppl 1():i62-3. PubMed ID: 15888759
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of squamous cell carcinoma of the head and neck with multi-drug chemotherapy and radiotherapy].
    Nishio M; Kagami Y; Narimatsu N; Asano K; Sanbe S; Somekawa Y
    Gan To Kagaku Ryoho; 1989 Sep; 16(9):3111-8. PubMed ID: 2476971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer.
    Machtay M; Rosenthal DI; Chalian AA; Lustig R; Hershock D; Miller L; Weinstein GS; Weber RS
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):72-7. PubMed ID: 15093901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less may be more: nodal treatment in neck positive head neck cancer patients.
    Studer G; Huber GF; Holz E; Glanzmann C
    Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1549-56. PubMed ID: 25920604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by surgery and concurrent chemoradiotherapy improves outcome of recurrent advanced head and neck squamous cell carcinoma.
    Yang WC; Chen CH; Tang JY; Wu CF; Liu YC; Sun Y; Lin SF
    Anticancer Res; 2014 Jul; 34(7):3765-73. PubMed ID: 24982400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy.
    Bingham HG
    Surg Clin North Am; 1986 Feb; 66(1):183-8. PubMed ID: 2418517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy for resectable squamous cell carcinoma of the head and neck. Report on Intergroup Study 0034.
    Hong WK
    Int J Radiat Oncol Biol Phys; 1992; 23(4):885-6. PubMed ID: 1618679
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.